✦ LIBER ✦

Patient selection key to cost-effective triple therapy in HCV

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient selection key to cost effective

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 205 KB

Reply to “Triple or dual therapy for HCV

✍ Palmieri, Orazio; Valvano, Maria Rosa; Margaglione, Maurizio; Andriulli, Angelo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Quality of life and cost-effectiveness o

✍ Maria Buti; John Wong; Miguel Angel Casado; Rafael Esteban 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Cost-Effectiveness Of Boceprevir Therapy

✍ Mernagh, P.; Feng, J.; Del Cuore, M 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

P1207 TRIPLE THERAPY FOR HCV CIRRHOSIS I

✍ Braithwaite, A.; Aguilera, V.; Vinaixa, C.; Garcia, M.; Benlloch, S.; Rubin, A.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

How to optimize HCV therapy in genotype

✍ Chopra, Angeli; Klein, Patricia L.; Drinnan, Thia; Lee, Samuel S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB